Xiel Ltd's sale to MIS Healthcare, advised by Evelyn Partners in Bristol

Somerset-based Xiel Ltd, which specialises in nuclear medicine, radiotherapy and diagnostic radiology, has been sold to London-based medical imaging firm MIS Healthcare, in a deal advised by Evelyn Partners Bristol.
The acquisition is a milestone for H2 Equity Partners portfolio company MIS Healthcare.
The latter generates over £50million revenue and it will support its strategy of becoming a leading diagnostic imaging service and equipment solutions provider with specialist oncology and radiotherapy capabilities.
Meanwhile, Xiel, based in Shepton Mallet, works with globally leading solution providers.
Its managing director Jack Knight said: "We are delighted to join forces with MIS Healthcare, an organisation that shares our commitment to delivering exceptional customer service and advancing cutting-edge technology within the healthcare sector.
"This merger brings an exciting opportunity to combine our extensive healthcare expertise and leverage the many synergies between our companies.
"Together, we will set new benchmarks in exceeding the expectations of our customers and suppliers. We look forward to this next chapter in Xiel’s journey and to achieving many future successes with MIS Healthcare."
Paul Stagg, Alex Sowerby and Alfred Wigmore of the Evelyn Partners corporate finance team in Bristol advised the shareholders of Xiel on the transaction.
Stagg said: "We wish the whole Xiel team all the best in the future. It was a pleasure to support the shareholders on the sale of their business being the latest owner-managers we have supported in achieving their strategic objectives."
Legal advice to Xiel was provided by Capital Law.